亚州一区二区三区中文字幕国产精品-日韩人妻一区二区三区蜜桃视频-亚洲中文字幕久久无码精品-午夜精品亚洲一区二区三区嫩草-日韩人妻一区二区三区蜜桃视频-国产一区二区精品高清在线观看-国产欧美日韩综合精品一区二区

The growing global cell therapy market is projected to reach more than $9 billion by2028. With such explosive growth and increasing demand for regenerative medicines, PPD, the clinical research business of Thermo Fisher Scientific, conducted asurvey in 2021 of executives engaged in cell therapy clinical trials at pharmaceutical and biopharmaceutical companies. 

The survey’s aim was to gain insights into the biggest challenges facing sponsor organizations and the solutions to those challenges offered by contract research organizations (CROs)that respondents find most satisfactory. Typical challenges investigated in the survey relateto chemistry, manufacturing and controls (CMC); logistics and storage; CRO project teamsand subject matter experts (SMEs); and patient follow up. The survey findings also revealedinsights about ongoing and planned cell therapy trials. Keep reading to learn more about thesurvey results.